The interim results of the Phase 3 SUCCESSOR-2 study's safety profile aligned with expectations for both mezigdomide and the combination regimen
The company announced positive topline data from the Phase II ZUPREME-1 trial
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications
Subscribe To Our Newsletter & Stay Updated
